Loewen Andrea 4
4 · REATA PHARMACEUTICALS INC · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Loewen Andrea
SVP, Global Regulatory Affairs
Transactions
- Award
Class A common stock
2023-01-03+11,756→ 44,612 total - Award
Employee Stock Option (right-to-buy)
2023-01-03+47,738→ 47,738 totalExercise: $36.71Exp: 2033-01-03→ Class A common stock (47,738 underlying)
Footnotes (2)
- [F1]The shares represent Restricted Stock Units, which vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.
- [F2]The options vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.